Jazz Pharmaceuticals

+$2.02 (+1.18%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell JAZZ and other stocks, options, and ETFs commission-free!

About JAZZ

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: Xyrem, Xywav, Sunosi, Erwinaze, Vyxeos, Defitelio, and Zepzelca.

CEO
Bruce C. Cozadd
Employees
1,940
Headquarters
Dublin, Dublin
Founded
2003

JAZZ Key Statistics

Market Cap
10.09B
Price-Earnings Ratio
37.94
Dividend Yield
—
Average Volume
815.21K
High Today
$173.00
Low Today
$166.50
Open Price
$167.81
Volume
1.04M
52 Week High
$178.64
52 Week Low
$101.81

JAZZ Earnings

$0.45
$1.77
$3.10
$4.42
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
$3.74 per share
Actual
$3.92 per share
Replay Earnings Call

You May Also Like

ADERU
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure